HEADER VIRAL PROTEIN 13-NOV-22 8HG0 TITLE CRYO-EM STRUCTURE OF SARS-COV-2 PROTOTYPE SPIKE PROTEIN RECEPTOR- TITLE 2 BINDING DOMAIN IN COMPLEX WITH WHITE-TAILED DEER ACE2 COMPND MOL_ID: 1; COMPND 2 MOLECULE: ANGIOTENSIN-CONVERTING ENZYME; COMPND 3 CHAIN: A; COMPND 4 EC: 3.4.-.-; COMPND 5 ENGINEERED: YES; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: SPIKE PROTEIN S1; COMPND 8 CHAIN: B; COMPND 9 SYNONYM: S GLYCOPROTEIN,E2,PEPLOMER PROTEIN; COMPND 10 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ODOCOILEUS VIRGINIANUS TEXANUS; SOURCE 3 ORGANISM_TAXID: 9880; SOURCE 4 GENE: ACE2; SOURCE 5 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 7 MOL_ID: 2; SOURCE 8 ORGANISM_SCIENTIFIC: SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS SOURCE 9 2; SOURCE 10 ORGANISM_COMMON: 2019-NCOV, SARS-COV-2; SOURCE 11 ORGANISM_TAXID: 2697049; SOURCE 12 GENE: S, 2; SOURCE 13 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 14 EXPRESSION_SYSTEM_TAXID: 9606 KEYWDS COMPLEX, VIRAL PROTEIN EXPDTA ELECTRON MICROSCOPY AUTHOR P.HAN,Y.M.MENG,J.X.QI REVDAT 2 25-OCT-23 8HG0 1 JRNL REVDAT 1 30-AUG-23 8HG0 0 JRNL AUTH P.HAN,Y.MENG,D.ZHANG,Z.XU,Z.LI,X.PAN,Z.ZHAO,L.LI,L.TANG, JRNL AUTH 2 J.QI,K.LIU,G.F.GAO JRNL TITL STRUCTURAL BASIS OF WHITE-TAILED DEER, ODOCOILEUS JRNL TITL 2 VIRGINIANUS , ACE2 RECOGNIZING ALL THE SARS-COV-2 VARIANTS JRNL TITL 3 OF CONCERN WITH HIGH AFFINITY. JRNL REF J.VIROL. V. 97 50523 2023 JRNL REFN ESSN 1098-5514 JRNL PMID 37676003 JRNL DOI 10.1128/JVI.00505-23 REMARK 2 REMARK 2 RESOLUTION. 3.51 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 SOFTWARE PACKAGES : UCSF CHIMERA, PHENIX REMARK 3 RECONSTRUCTION SCHEMA : NULL REMARK 3 REMARK 3 EM MAP-MODEL FITTING AND REFINEMENT REMARK 3 PDB ENTRY : NULL REMARK 3 REFINEMENT SPACE : NULL REMARK 3 REFINEMENT PROTOCOL : NULL REMARK 3 REFINEMENT TARGET : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE : NULL REMARK 3 REMARK 3 FITTING PROCEDURE : NULL REMARK 3 REMARK 3 EM IMAGE RECONSTRUCTION STATISTICS REMARK 3 NOMINAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 ACTUAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 EFFECTIVE RESOLUTION (ANGSTROMS) : 3.510 REMARK 3 NUMBER OF PARTICLES : 123232 REMARK 3 CTF CORRECTION METHOD : PHASE FLIPPING AND AMPLITUDE REMARK 3 CORRECTION REMARK 3 REMARK 3 EM RECONSTRUCTION MAGNIFICATION CALIBRATION: NULL REMARK 3 REMARK 3 OTHER DETAILS: NULL REMARK 4 REMARK 4 8HG0 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBC ON 17-NOV-22. REMARK 100 THE DEPOSITION ID IS D_1300033073. REMARK 245 REMARK 245 EXPERIMENTAL DETAILS REMARK 245 RECONSTRUCTION METHOD : SINGLE PARTICLE REMARK 245 SPECIMEN TYPE : NULL REMARK 245 REMARK 245 ELECTRON MICROSCOPE SAMPLE REMARK 245 SAMPLE TYPE : PARTICLE REMARK 245 PARTICLE TYPE : POINT REMARK 245 NAME OF SAMPLE : SARS-COV-2 PROTOTYPE SPIKE REMARK 245 PROTEIN RECEPTOR-BINDING DOMAIN REMARK 245 IN COMPLEX WITH WHITE-TAILED REMARK 245 DEER ACE2 REMARK 245 SAMPLE CONCENTRATION (MG ML-1) : NULL REMARK 245 SAMPLE SUPPORT DETAILS : NULL REMARK 245 SAMPLE VITRIFICATION DETAILS : NULL REMARK 245 SAMPLE BUFFER : NULL REMARK 245 PH : 8.00 REMARK 245 SAMPLE DETAILS : NULL REMARK 245 REMARK 245 DATA ACQUISITION REMARK 245 DATE OF EXPERIMENT : NULL REMARK 245 NUMBER OF MICROGRAPHS-IMAGES : NULL REMARK 245 TEMPERATURE (KELVIN) : NULL REMARK 245 MICROSCOPE MODEL : FEI TITAN KRIOS REMARK 245 DETECTOR TYPE : GATAN K3 (6K X 4K) REMARK 245 MINIMUM DEFOCUS (NM) : 1000.00 REMARK 245 MAXIMUM DEFOCUS (NM) : 2000.00 REMARK 245 MINIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 MAXIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 NOMINAL CS : NULL REMARK 245 IMAGING MODE : BRIGHT FIELD REMARK 245 ELECTRON DOSE (ELECTRONS NM**-2) : 6000.00 REMARK 245 ILLUMINATION MODE : FLOOD BEAM REMARK 245 NOMINAL MAGNIFICATION : NULL REMARK 245 CALIBRATED MAGNIFICATION : NULL REMARK 245 SOURCE : FIELD EMISSION GUN REMARK 245 ACCELERATION VOLTAGE (KV) : 300 REMARK 245 IMAGING DETAILS : NULL REMARK 247 REMARK 247 ELECTRON MICROSCOPY REMARK 247 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM ELECTRON REMARK 247 MICROSCOPY DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE REMARK 247 THAT CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES REMARK 247 ON THESE RECORDS ARE MEANINGLESS EXCEPT FOR THE CALCULATION REMARK 247 OF THE STRUCTURE FACTORS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 2 REMARK 465 THR A 3 REMARK 465 GLY A 4 REMARK 465 SER A 5 REMARK 465 PHE A 6 REMARK 465 TRP A 7 REMARK 465 LEU A 8 REMARK 465 LEU A 9 REMARK 465 LEU A 10 REMARK 465 SER A 11 REMARK 465 LEU A 12 REMARK 465 VAL A 13 REMARK 465 ALA A 14 REMARK 465 VAL A 15 REMARK 465 THR A 16 REMARK 465 ALA A 17 REMARK 465 ALA A 18 REMARK 465 GLN A 19 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 THR A 22 CG2 REMARK 470 THR A 83 CG2 REMARK 470 THR A 106 CG2 REMARK 470 THR A 119 CG2 REMARK 470 THR A 138 CG2 REMARK 470 THR A 210 CG2 REMARK 470 THR A 259 CG2 REMARK 470 THR A 578 CG2 REMARK 470 THR A 611 CG2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 171 -60.68 -91.32 REMARK 500 GLU A 211 -82.03 174.11 REMARK 500 HIS A 322 -179.76 -67.70 REMARK 500 ASN A 330 14.95 57.19 REMARK 500 ILE A 484 -62.21 -101.15 REMARK 500 ASP A 494 -169.16 -125.76 REMARK 500 PRO B 521 45.15 -76.57 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A 703 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS A 374 NE2 REMARK 620 2 HIS A 378 NE2 111.9 REMARK 620 3 GLU A 402 OE2 110.8 109.9 REMARK 620 N 1 2 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: EMD-34730 RELATED DB: EMDB REMARK 900 CRYO-EM STRUCTURE OF SARS-COV-2 PROTOTYPE SPIKE PROTEIN RECEPTOR- REMARK 900 BINDING DOMAIN IN COMPLEX WITH WHITE-TAILED DEER ACE2 DBREF1 8HG0 A 2 614 UNP A0A6J0Z472_ODOVR DBREF2 8HG0 A A0A6J0Z472 1 613 DBREF 8HG0 B 333 527 UNP P0DTC2 SPIKE_SARS2 333 527 SEQRES 1 A 613 MET THR GLY SER PHE TRP LEU LEU LEU SER LEU VAL ALA SEQRES 2 A 613 VAL THR ALA ALA GLN SER THR THR GLU GLU GLN ALA LYS SEQRES 3 A 613 THR PHE LEU GLU LYS PHE ASN HIS GLU ALA GLU ASP LEU SEQRES 4 A 613 SER TYR GLN SER SER LEU ALA SER TRP ASN TYR ASN THR SEQRES 5 A 613 ASN ILE THR ASP GLU ASN VAL GLN LYS MET ASN GLU ALA SEQRES 6 A 613 ARG ALA LYS TRP SER ALA PHE TYR GLU GLU GLN SER ARG SEQRES 7 A 613 MET ALA LYS THR TYR SER LEU GLU GLU ILE GLN ASN LEU SEQRES 8 A 613 THR LEU LYS ARG GLN LEU LYS ALA LEU GLN GLN SER GLY SEQRES 9 A 613 THR SER VAL LEU SER ALA GLU LYS SER LYS ARG LEU ASN SEQRES 10 A 613 THR ILE LEU ASN THR MET SER THR ILE TYR SER THR GLY SEQRES 11 A 613 LYS VAL LEU ASP PRO ASN THR GLN GLU CYS LEU ALA LEU SEQRES 12 A 613 GLU PRO GLY LEU ASP ASP ILE MET GLU ASN SER ARG ASP SEQRES 13 A 613 TYR ASN ARG ARG LEU TRP ALA TRP GLU GLY TRP ARG ALA SEQRES 14 A 613 GLU VAL GLY LYS GLN LEU ARG PRO LEU TYR GLU GLU TYR SEQRES 15 A 613 VAL VAL LEU GLU ASN GLU MET ALA ARG ALA ASN ASN TYR SEQRES 16 A 613 GLU ASP TYR GLY ASP TYR TRP ARG GLY ASP TYR GLU VAL SEQRES 17 A 613 THR GLU ALA GLY ASP TYR ASP TYR SER ARG ASP GLN LEU SEQRES 18 A 613 MET LYS ASP VAL GLU ASN THR PHE ALA GLU ILE LYS PRO SEQRES 19 A 613 LEU TYR GLU GLN LEU HIS ALA TYR VAL ARG ALA LYS LEU SEQRES 20 A 613 MET ASP THR TYR PRO SER TYR ILE SER PRO THR GLY CYS SEQRES 21 A 613 LEU PRO ALA HIS LEU LEU GLY ASP MET TRP GLY ARG PHE SEQRES 22 A 613 TRP THR ASN LEU TYR SER LEU THR VAL PRO PHE LYS HIS SEQRES 23 A 613 LYS PRO SER ILE ASP VAL THR GLU LYS MET LYS ASN GLN SEQRES 24 A 613 SER TRP ASP ALA GLU ARG ILE PHE LYS GLU ALA GLU LYS SEQRES 25 A 613 PHE PHE VAL SER ILE SER LEU PRO HIS MET THR GLN GLY SEQRES 26 A 613 PHE TRP ASP ASN SER MET LEU THR GLU PRO GLY ASP GLY SEQRES 27 A 613 ARG LYS VAL VAL CYS HIS PRO THR ALA TRP ASP LEU GLY SEQRES 28 A 613 LYS GLY ASP PHE ARG ILE LYS MET CYS THR LYS VAL THR SEQRES 29 A 613 MET ASP ASP PHE LEU THR ALA HIS HIS GLU MET GLY HIS SEQRES 30 A 613 ILE GLN TYR ASP MET ALA TYR ALA ALA GLN PRO TYR LEU SEQRES 31 A 613 LEU ARG ASP GLY ALA ASN GLU GLY PHE HIS GLU ALA VAL SEQRES 32 A 613 GLY GLU ILE MET SER LEU SER ALA ALA THR PRO HIS TYR SEQRES 33 A 613 LEU LYS ALA LEU GLY LEU LEU GLU PRO ASP PHE TYR GLU SEQRES 34 A 613 ASP ASN GLU THR GLU ILE ASN PHE LEU LEU LYS GLN ALA SEQRES 35 A 613 LEU THR ILE VAL GLY THR LEU PRO PHE THR TYR MET LEU SEQRES 36 A 613 GLU LYS TRP ARG TRP MET VAL PHE LYS GLY GLU ILE PRO SEQRES 37 A 613 LYS GLU GLN TRP MET GLU LYS TRP TRP GLU MET LYS ARG SEQRES 38 A 613 GLU ILE VAL GLY VAL VAL GLU PRO LEU PRO HIS ASP GLU SEQRES 39 A 613 THR TYR CYS ASP PRO ALA CYS LEU PHE HIS VAL ALA GLU SEQRES 40 A 613 ASP TYR SER PHE ILE ARG TYR TYR THR ARG THR ILE TYR SEQRES 41 A 613 GLN PHE GLN PHE HIS GLU ALA LEU CYS LYS THR ALA ASN SEQRES 42 A 613 HIS GLU GLY ALA LEU PHE LYS CYS ASP ILE SER ASN SER SEQRES 43 A 613 THR GLU ALA GLY GLN ARG LEU LEU GLN MET LEU SER LEU SEQRES 44 A 613 GLY LYS SER GLU PRO TRP THR LEU ALA LEU GLU SER ILE SEQRES 45 A 613 VAL GLY ILE LYS THR MET ASP VAL LYS PRO LEU LEU ASN SEQRES 46 A 613 TYR PHE GLU PRO LEU PHE THR TRP LEU LYS GLU GLN ASN SEQRES 47 A 613 ARG ASN SER PHE VAL GLY TRP SER THR GLU TRP THR PRO SEQRES 48 A 613 TYR SER SEQRES 1 B 195 THR ASN LEU CYS PRO PHE GLY GLU VAL PHE ASN ALA THR SEQRES 2 B 195 ARG PHE ALA SER VAL TYR ALA TRP ASN ARG LYS ARG ILE SEQRES 3 B 195 SER ASN CYS VAL ALA ASP TYR SER VAL LEU TYR ASN SER SEQRES 4 B 195 ALA SER PHE SER THR PHE LYS CYS TYR GLY VAL SER PRO SEQRES 5 B 195 THR LYS LEU ASN ASP LEU CYS PHE THR ASN VAL TYR ALA SEQRES 6 B 195 ASP SER PHE VAL ILE ARG GLY ASP GLU VAL ARG GLN ILE SEQRES 7 B 195 ALA PRO GLY GLN THR GLY LYS ILE ALA ASP TYR ASN TYR SEQRES 8 B 195 LYS LEU PRO ASP ASP PHE THR GLY CYS VAL ILE ALA TRP SEQRES 9 B 195 ASN SER ASN ASN LEU ASP SER LYS VAL GLY GLY ASN TYR SEQRES 10 B 195 ASN TYR LEU TYR ARG LEU PHE ARG LYS SER ASN LEU LYS SEQRES 11 B 195 PRO PHE GLU ARG ASP ILE SER THR GLU ILE TYR GLN ALA SEQRES 12 B 195 GLY SER THR PRO CYS ASN GLY VAL GLU GLY PHE ASN CYS SEQRES 13 B 195 TYR PHE PRO LEU GLN SER TYR GLY PHE GLN PRO THR ASN SEQRES 14 B 195 GLY VAL GLY TYR GLN PRO TYR ARG VAL VAL VAL LEU SER SEQRES 15 B 195 PHE GLU LEU LEU HIS ALA PRO ALA THR VAL CYS GLY PRO HET NAG A 701 14 HET NAG A 702 14 HET ZN A 703 1 HET NAG B 601 14 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM ZN ZINC ION HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE FORMUL 3 NAG 3(C8 H15 N O6) FORMUL 5 ZN ZN 2+ HELIX 1 AA1 THR A 21 ASN A 54 1 34 HELIX 2 AA2 THR A 56 LYS A 82 1 27 HELIX 3 AA3 ASN A 91 GLN A 103 1 13 HELIX 4 AA4 GLY A 105 LEU A 109 5 5 HELIX 5 AA5 SER A 110 THR A 130 1 21 HELIX 6 AA6 PRO A 146 SER A 155 1 10 HELIX 7 AA7 ASP A 157 ASN A 194 1 38 HELIX 8 AA8 ASP A 198 ARG A 204 1 7 HELIX 9 AA9 GLY A 205 GLU A 208 5 4 HELIX 10 AB1 SER A 218 MET A 223 1 6 HELIX 11 AB2 ASP A 225 TYR A 252 1 28 HELIX 12 AB3 HIS A 265 LEU A 267 5 3 HELIX 13 AB4 TRP A 275 TYR A 279 5 5 HELIX 14 AB5 VAL A 293 LYS A 298 1 6 HELIX 15 AB6 ASN A 299 TRP A 302 5 4 HELIX 16 AB7 ASP A 303 ILE A 318 1 16 HELIX 17 AB8 THR A 324 ASP A 329 1 6 HELIX 18 AB9 THR A 365 TYR A 385 1 21 HELIX 19 AC1 PRO A 389 ARG A 393 5 5 HELIX 20 AC2 GLY A 399 THR A 414 1 16 HELIX 21 AC3 THR A 414 LEU A 421 1 8 HELIX 22 AC4 ASP A 431 VAL A 447 1 17 HELIX 23 AC5 GLY A 448 GLY A 466 1 19 HELIX 24 AC6 PRO A 469 GLU A 471 5 3 HELIX 25 AC7 GLN A 472 ILE A 484 1 13 HELIX 26 AC8 ASP A 499 CYS A 502 5 4 HELIX 27 AC9 LEU A 503 GLU A 508 1 6 HELIX 28 AD1 ILE A 513 THR A 532 1 20 HELIX 29 AD2 SER A 547 SER A 559 1 13 HELIX 30 AD3 PRO A 565 GLY A 575 1 11 HELIX 31 AD4 VAL A 581 ARG A 600 1 20 HELIX 32 AD5 PRO B 337 ASN B 343 1 7 HELIX 33 AD6 TYR B 365 SER B 371 1 7 HELIX 34 AD7 GLY B 416 ASN B 422 1 7 HELIX 35 AD8 SER B 438 SER B 443 1 6 SHEET 1 AA1 2 LYS A 132 VAL A 133 0 SHEET 2 AA1 2 LEU A 142 ALA A 143 -1 O LEU A 142 N VAL A 133 SHEET 1 AA2 2 LEU A 262 PRO A 263 0 SHEET 2 AA2 2 VAL A 487 VAL A 488 1 O VAL A 488 N LEU A 262 SHEET 1 AA3 2 THR A 347 GLY A 352 0 SHEET 2 AA3 2 ASP A 355 LYS A 359 -1 O LYS A 359 N THR A 347 SHEET 1 AA4 5 ASN B 354 ILE B 358 0 SHEET 2 AA4 5 ASN B 394 ARG B 403 -1 O VAL B 395 N ILE B 358 SHEET 3 AA4 5 PRO B 507 GLU B 516 -1 O TYR B 508 N ILE B 402 SHEET 4 AA4 5 GLY B 431 ASN B 437 -1 N ILE B 434 O VAL B 511 SHEET 5 AA4 5 THR B 376 TYR B 380 -1 N LYS B 378 O VAL B 433 SHEET 1 AA5 2 LEU B 452 ARG B 454 0 SHEET 2 AA5 2 LEU B 492 SER B 494 -1 O GLN B 493 N TYR B 453 SHEET 1 AA6 2 TYR B 473 GLN B 474 0 SHEET 2 AA6 2 CYS B 488 TYR B 489 -1 O TYR B 489 N TYR B 473 SSBOND 1 CYS A 344 CYS A 361 1555 1555 2.03 SSBOND 2 CYS A 530 CYS A 542 1555 1555 2.03 SSBOND 3 CYS B 336 CYS B 361 1555 1555 2.03 SSBOND 4 CYS B 379 CYS B 432 1555 1555 2.03 SSBOND 5 CYS B 391 CYS B 525 1555 1555 2.04 SSBOND 6 CYS B 480 CYS B 488 1555 1555 2.03 LINK ND2 ASN A 299 C1 NAG A 701 1555 1555 1.44 LINK ND2 ASN A 432 C1 NAG A 702 1555 1555 1.44 LINK ND2 ASN B 343 C1 NAG B 601 1555 1555 1.44 LINK NE2 HIS A 374 ZN ZN A 703 1555 1555 2.10 LINK NE2 HIS A 378 ZN ZN A 703 1555 1555 2.10 LINK OE2 GLU A 402 ZN ZN A 703 1555 1555 2.10 CISPEP 1 GLU A 145 PRO A 146 0 -7.73 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000